We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
Cap. Flow
-$193M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$97.3M
2
AGN
Allergan Inc
AGN
+$79.1M
3
MU icon
Micron Technology
MU
+$67M
4
HPQ icon
HP
HPQ
+$65.4M
5
BAX icon
Baxter International
BAX
+$55.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.38%
2 Financials 13.7%
3 Communication Services 11.26%
4 Technology 9.89%
5 Industrials 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEGI
301
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$5.35M 0.07%
188,859
+145,408
+335% +$4.08M
UNM icon
302
Unum
UNM
$13.8B
$5.3M 0.07%
157,250
+150,874
+2,366% +$5.01M
RAD
303
DELISTED
Rite Aid Corporation
RAD
$5.3M 0.07%
30,478
-75,818
-71% -$11.8M
ZNGA
304
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$5.29M 0.07%
1,857,701
+1,292,707
+229% +$3.34M
OII icon
305
Oceaneering
OII
$5.25B
$5.27M 0.07%
97,753
-51,338
-34% -$2.74M
GILD icon
306
Gilead Sciences
GILD
$161B
$5.25M 0.07%
53,551
-233,247
-81% -$23.7M
DTSI
307
DELISTED
DTS, Inc.
DTSI
$5.24M 0.07%
+153,736
New +$4.71M
TARO
308
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$5.22M 0.07%
37,029
-59,988
-62% -$9.23M
SIAL
309
DELISTED
SIGMA - ALDRICH CORP
SIAL
$5.13M 0.07%
37,111
+7,853
+27% +$1.08M
MA icon
310
Mastercard
MA
$477B
$5.12M 0.07%
59,262
-159,973
-73% -$13.9M
PX
311
DELISTED
Praxair Inc
PX
$5.08M 0.07%
42,123
-165,001
-80% -$20.6M
STL
312
DELISTED
Sterling Bancorp
STL
$5.08M 0.07%
+378,937
New +$5.15M
GLPI icon
313
Gaming and Leisure Properties
GLPI
$12.8B
$5.08M 0.07%
+137,670
New +$4.65M
NFLX icon
314
Netflix
NFLX
$292B
$5.08M 0.07%
852,600
+619,220
+265% +$3.76M
FNSR
315
DELISTED
Finisar Corp
FNSR
$5.05M 0.07%
236,575
-54,449
-19% -$1.11M
CNL
316
DELISTED
CLECO CRP (HOLDING CO)
CNL
$5.02M 0.07%
92,000
+45,400
+97% +$2.47M
HAR
317
DELISTED
Harman International Industries
HAR
$4.99M 0.07%
37,302
+34,276
+1,133% +$4.26M
STE icon
318
Steris
STE
$20.9B
$4.94M 0.06%
+70,240
New +$4.63M
STNG icon
319
Scorpio Tankers
STNG
$3.96B
$4.93M 0.06%
52,393
+41,864
+398% +$3.64M
GPRE icon
320
Green Plains
GPRE
$1.19B
$4.93M 0.06%
172,614
-209,937
-55% -$5.25M
NVGS icon
321
Navigator Holdings
NVGS
$1.34B
$4.9M 0.06%
256,560
+74,136
+41% +$1.34M
WMS icon
322
Advanced Drainage Systems
WMS
$10.9B
$4.86M 0.06%
162,227
-121,469
-43% -$3.16M
COLM icon
323
Columbia Sportswear
COLM
$3.19B
$4.82M 0.06%
+79,146
New +$4M
MPAA icon
324
Motorcar Parts of America
MPAA
$261M
$4.8M 0.06%
172,652
+68,003
+65% +$1.85M
CELG
325
DELISTED
Celgene Corp
CELG
$4.79M 0.06%
41,528
-95,201
-70% -$11.4M

Similar funds

Marshall Wace's Q1 2015 Portfolio in Review

As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.

  • Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
  • Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
  • Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
  • Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
  • Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
  • Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.

Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.